ISRG · 8-K · 20261020PR000067
Antitrust Litigation Settlement
INTUITIVE SURGICAL INC · 2026-10-20 · Importance 96 · Surprise 100 · In source text
Intuitive agreed to settle the previously disclosed da Vinci surgical robot antitrust class action litigation for a one-time payment of $450 million and mutually agreed injunctive relief. The company recorded a $454.9 million selling, general, and administrative litigation charge in the third quarter, compared with $8.1 million in the prior-year quarter. The charge reduced third-quarter net income by $347 million after tax, or $0.99 per diluted share. The settlement remained subject to preliminary and final court approval and could be affected by objections from class members.
Key facts
- In October 2026 the Company reached written agreement to settle the antitrust class action for a one-time payment of $450 million and mutually agreed injunctive relief. source
- The Company recorded a $450 million charge to selling, general, and administrative expenses in Q3 2026 related to the settlement. source
- The third quarter 2026 antitrust settlement expense was $347 million, net of tax, or $0.99 per diluted share. source
- The settlement remains subject to preliminary and final Court approval and there can be no assurance the Court will approve it or that individual class members will not object. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | -15.6% | The Company recorded a $450 million charge to selling, general, and administrative expenses in Q3 2026 related to the settlement. |
| net_income | negative | realized | -12.0% | The third quarter 2026 antitrust settlement expense was $347 million, net of tax, or $0.99 per diluted share. |
| liability | negative | committed | -1.8% | In October 2026 the Company reached written agreement to settle the antitrust class action for a one-time payment of $450 million and… |
| liability | negative | contingent | — | The settlement remains subject to preliminary and final Court approval and there can be no assurance the Court will approve it or that… |